Von professionellen Übersetzern, Unternehmen, Websites und kostenlos verfügbaren Übersetzungsdatenbanken.
slow jam
hidas jami
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
espaciadothe compression will take a long time; saving the file will be slow.
välistys
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
comprimir: the compression will take a long time; saving the file will be slow.
ominaisuudet:
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
c linical investigation of slow- a c t ing anti- rheumatic medic inal products in rheumatoid arthritis
clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
Warnung: Diese Ausrichtung könnte falsch sein.
Bitte löschen Sie diese, wenn Sie dieser Ansicht sind.
famosas organizaciones no gubernamentales independientes, tales como slow food international, greenpeace o vier pfoten han manifestado su apoyo a la iniciativa.
tunnetut riippumattomat kansalaisjärjestöt, kuten slow food international, greenpeace ja vier pfoten, ovat antaneet aloitteelle monenlaista tukea.
Letzte Aktualisierung: 2014-02-06
Nutzungshäufigkeit: 1
Qualität:
velocidad rápida: ejecuta el programa a velocidad rápida@option: radio choose the slow speed
@ option: radio choose the slow speed
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
Letzte Aktualisierung: 2011-10-23
Nutzungshäufigkeit: 1
Qualität:
Warnung: Diese Ausrichtung könnte falsch sein.
Bitte löschen Sie diese, wenn Sie dieser Ansicht sind.